Substance-focused SBI as a Complement to Internet-based Psychiatric Treatment: RCT (eScreeniPsy)

Karolinska Institute

Status: Completed

Conditions: Substance Use Disorders (SUD)

Treatments: Behavioral: Internet-based treatment for depression or anxiety; Behavioral: Assessment only of alcohol and drug use.; Behavioral: eScreen

Study type: Interventional

Funder types: Other

Identifiers

NCT01885026

KI 4-2007/2013 (Other Identifier)

2012/1138-31/1

Details and patient eligibility

About

Objectives: This study evaluates the efficacy of eScreen for internet psychiatry patients treated for major depressive disorder, panic anxiety and social phobia. The eScreen brief Internet intervention for problematic alcohol and drug use offers self-screening, in-depth self-reporting, personalized feedback and treatment recommendations as well as an electronic diary. Progress over time is shown in diagrams detailing consumption levels.

Method: This is a two-armed randomized controlled design, measuring outcomes in terms of changes in problematic alcohol use up to one year after study recruitment. Participants with problematic alcohol use (AUDIT >7 for men and >5 for women) and/or problematic drug use (DUDIT > 1 for both men and women) are randomized into one of two groups: T1, eScreen referral or Control group. Outcomes on alcohol and drug use as well as health-related symptoms are assessed after 3, 6 and 12 months.

The hypothesis is that the group receiving the eScreen intervention will reduce their alcohol/drug use to a larger extent than the control group at follow-up compared to the baseline level.

Full description

This study evaluated the efficacy of eScreen for internet psychiatry patients treated for major depressive disorder, panic anxiety and social phobia. The eScreen brief Internet intervention for problematic alcohol and drug use offers self-screening, in-depth self-reporting, personalized feedback and treatment recommendations as well as an electronic diary. Progress over time is shown in diagrams detailing consumption levels. The design was a two-armed randomized controlled design, measuring outcomes in terms of changes in problematic alcohol use up to one year after study recruitment. Participants with problematic alcohol use (AUDIT >7 for men and >5 for women) and/or problematic drug use (DUDIT > 1 for both men and women) were randomized into one of two groups: T1, eScreen referral or Control group. Outcomes on alcohol and drug use as well as health-related symptoms are assessed after 3, 6 and 12 months.

The hypothesis was that the group receiving the eScreen intervention would reduce their alcohol/drug use to a larger extent than the control group at follow-up compared to the baseline level. The results have not yet been analyzed due to technical issues. However, qualitative interviews have been conducted with participants and our intention is to publish the qualitative results in tandem with the quantitative results available.

Enrollment: 93 patients

Sex: All

Ages: 15+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

AUDIT >7 for men and AUDIT >5 for women, and/or DUDIT >0

Exclusion criteria

DUDIT = 0 and AUDIT <8 (men) or <6 (women)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

93 participants in 2 patient groups

eScreen

Experimental group

Description:

Web based self-monitoring of problematic alcohol and drug use, and Internet-based treatment for depression or anxiety

Treatment:

Behavioral: eScreen

Behavioral: Internet-based treatment for depression or anxiety

Control

Experimental group

Description:

Assessment only of alcohol and drug use and Internet-based treatment for depression or anxiety

Treatment:

Behavioral: Assessment only of alcohol and drug use.

Behavioral: Internet-based treatment for depression or anxiety